CYTK vs JD · rev $28.6M vs P/E 7.6, rev $187.20B
Cytokinetics Inc (CYTK) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
CYTK currently screens at market cap $4.05B. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the CYTK and JD stock pages for the full models.
Not investment advice.